# Alignment of PrEP Use With HIV Risk in Young Women and Men

> **NCT04664998** · PHASE4 · COMPLETED · sponsor: **University of Washington** · enrollment: 212 (actual)

## Conditions studied

- Pre-Exposure Prophylaxis
- Sexually Transmitted Diseases, Bacterial
- HIV Infections

## Interventions

- **DRUG:** Daily oral PrEP
- **DRUG:** Daily oral PrEP

## Key facts

- **NCT ID:** NCT04664998
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-01
- **Primary completion:** 2023-12-10
- **Final completion:** 2023-12-10
- **Target enrollment:** 212 (ACTUAL)
- **Last updated:** 2025-06-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04664998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04664998, "Alignment of PrEP Use With HIV Risk in Young Women and Men". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04664998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*